Afuco™ Anti-Human IL13RA2 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-IL13RA2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The discovery that cancer cells that have no or low expression of the IL-13 receptor (IL-13R) can bind IL-13R-targeted immunoconjugates, such as immunotoxins, by transfection with the IL-13Rα2 chain alone. The anti-IL-13α2 antibodies are used for treat cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-381CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | IL13RA2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Short term: store at 4°C (over 6 months), long term: -20°C or -80°C. |